The Alliance for Artificial Intelligence in Healthcare (AAIH) has officially launched after the board of directors held the organization’s inaugural meeting Jan. 9 in San Francisco.

A report from Persistence Marketing Research predicts the demand for neurovascular thrombectomy devices (NTDs), particularly stent retrievers, will surge in the near future alongside a growing prevalence of cerebral infarction and ischemic stroke.

The new evidence-based clinical recommendations seek to help labs better use quantitative image analysis (QIA) in HER2 testing for breast cancer.

Following a series of valsartan recalls over carcinogenic impurities, at least three sellers of the popular blood-pressure medication hiked their prices, the Wall Street Journal reported.

It was a record-breaking year for global venture capital (VC) funding in digital health, with more than $9.5 billion raised in 698 deals for 2018, according to a report by Mercom Capital Group. The previous record was set last year, with $7.2 billion raised in 778 deals.

Healthcare spending on wearables is expected to reach $60 billion by 2023 as the technology becomes more popular within the medical industry, according to a recent report by Juniper Research.

Interventional cardiologist Kipp Webb and representatives from Montana’s Bozeman Health Deaconess Hospital entered a 19-day jury trial Jan. 17 after Webb claimed the hospital created a monopoly over cardiology services in 2011, preventing him from practicing in the area.

Bayer will be closing its administrative offices in Robinson Township, Pennsylvania, affecting more than 500 jobs and another 96 contract positions. The decision comes months after Bayer announced that it will be laying off 12,000 workers by 2021.